2026 Drug Prices

A brand new year and time for the Old Professor to get back to work.

Regardless what you have been told by Uncle Donny drug prices will increase this year and as an FYI for those that have to pay the piper for their meds I wan t you to know what is in store for you and your wallet….

Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including vaccines for COVID-19 and shingles, migraine treatments, and blockbuster cancer drugs, according to data provided to Reuters by healthcare research firm 3 Axis Advisors.

The number of planned increases is up from the same point last year, when companies announced hikes on more than 250 drugs. The median increase for 2026 is about 4%, roughly in line with 2025. These figures reflect list prices before rebates or discounts negotiated with insurers and pharmacy benefit managers.

The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients and government programs. President Donald Trump has touted deals with 14 drugmakers to reduce prices for Medicaid and cash-paying customers, but analysts say those agreements barely dent overall spending.

Pfizer announced the most increases, with hikes on about 80 drugs and vaccines, according to Reuters. Most are below 10%, but some stand out: Comirnaty, its COVID-19 vaccine, will rise by 15%. Paxlovid, the company’s COVID-19 antiviral, is also on the list, along with Ibrance, a breast cancer treatment, and Nurtec, a migraine pill. Hospital-administered drugs such as morphine and hydromorphone will see some of the steepest hikes, with certain formulations increasing more than four-fold.

Pfizer said in a statement that its adjustments keep average list prices below inflation and are necessary to fund research and offset rising costs.

“The modest increase is necessary to support investments that allow us to continue to discover and deliver new medicines,” the company said.

(What a bold face pile of bullshit!  But elsewhere the drugs, same drugs, are cheaper….put that in your pipe and smoke it)

https://www.newsweek.com/medications-drugs-vaccines-price-increases-2026-11290128

So much for that 1500% savings that Donny promised a few months back.

You might want to read the stuff carefully and see if you may be in for a rude awakening….just a suggestion.

The new year is already started out a sucky tone.

I Read, I Write, You Know

“lego ergo scribo”

How About Dem Drug Prices?

What made me want to post on this topic was last month I got ticket shock when I picked up my meds and were told that it would be $536 for a month’s supply.

Then I started wondering what had happened to all those promises from Biden and his Dem cohorts…..what is going on these days with our drug prices?

There is a fight coming over the Medicare pricing reform….PhARMA is not happy and has gone to court….

A federal judge on Monday dismissed a lawsuit that the pharmaceutical industry’s powerful trade group and allied organizations filed in an attempt to kill Medicare’s new drug price negotiation program, which threatens manufacturers’ virtually unrestrained power to drive up the prices of lifesaving medicines.

Judge David Alan Ezra of the U.S. District Court for the Western District of Texas tossed the lawsuit on procedural grounds, ruling that the National Infusion Center Association (NICA)—which does not manufacture or sell prescription drugs—lacked standing to sue.

Because NICA was the only plaintiff based in Texas, Ezra—a Reagan appointee—dismissed the lawsuit, which was joined by Pharmaceutical Research and Manufacturers of America (PhRMA) and the Global Colon Cancer Association. The coalition argued that the Medicare price negotiation program is unconstitutional, a claim that advocates have dismissed as cover for the industry’s attempt to protect its profits.

A spokesperson for PhRMA, which spends tens of millions of dollars a year lobbying Congress, told Axios in a statement that the group is “disappointed” with the judge’s decision and is weighing its next legal steps.

https://www.commondreams.org/news/judge-tosses-pharma-lawsuit

At least one judge is on our side but I would not get too cocky….if it goes to SCOTUS it will screw us mere peasants for at least one spouse of a sitting judge is in the pocket of PhARMA.

Speaking of lobbyists….last year, 2022, PhARMA spent $374 million on buying support from Congress.

Then there is whopping bonuses the CEOs are raking in…..

Could any corporate execs walking our world today be any greedier than the execs who run Big Pharma? Hard to say. But out-grasping Big Pharma, suggests a new report out of the U.S. Senate Committee on Health, Education, Labor, and Pensions, would certainly require some serious greed.

Consider, for instance, the pay record of the Big Pharma colossus Johnson & Johnson.

Two years ago, Johnson & Johnson pocketed $17.9 billion in profits and rewarded its CEO with $27.6 million in compensation. That same year, overall, saw Johnson & Johnson lay out $17.8 billion on stock buybacks, dividends, and executive pay — and only $14.6 billion on R&D.

“In other words,” the Senate panel’s report noted, “the company spent $3.2 billion more enriching executives and stockholders than finding new cures.”

New Hope for a Check on CEO Compensation

Did you read that?   PhARMA spent more on stock buy backs than it did on R&D….recovering R&D is one of the excuses for high prices.

Enough is enough!

Promises do not pay the bills….time to get serious about controlling drug prices or STFU and go home!

Pharmaceutical companies are angry with Bernie Sanders. The Vermont senator has vowed to force pharma CEOs to publicly answer for why their drug prices are so much higher in the United States than in other nations.

Brazenly, the CEOs of Johnson & Johnson and Merck initially refused.

An attorney for Johnson & Johnson accused the senator of using Senate committee hearings to “punish the companies who have chosen to engage in constitutionally protected litigation.” The company, along with Merck and Bristol Myers Squibb, issuing the Biden administration for allowing Medicare to regulate certain prescription drug prices.

For the last two decades, it’s been a free-for-all for pharmaceutical companies in the U.S.

In 2003, then-President George W. Bush signed a Medicare reform bill into law, promising help for seniors struggling to pay for medications. But that law stripped the federal government of its power to negotiate drug prices for Medicare’s participants. And that’s driven drug prices up for everyone.

Drug Prices Should be Controlled

Will us peasants ever be the one thing on Congress’ collective mind?  Or are we just a means to an end?

I believe the later is true.

How about you?

I Read, I Write, You Know

“lego ergo scribo”

Drugs And You

If you are a senior that has to take medications or a regular person the new year will bring us more expensive drugs…..something else to look forward to in this new year.

Big Pharma is set to screw the public again…..

Drugmakers including Pfizer Inc (PFE.N), GlaxoSmithKline PLC (GSK.L), Bristol Myers Squibb (BMY.N), AstraZeneca PLC (AZN.L) and Sanofi SA (SASY.PA) plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.

The increases are expected to come as the pharmaceutical industry prepares for the Biden Administration’s Inflation Reduction Act (IRA), which allows the government’s Medicare health program to negotiate prices directly for some drugs starting in 2026. The industry is also contending with inflation and supply chain constraints that have led to higher manufacturing costs.

The increases are on list prices, which do not include rebates to pharmacy benefit managers and other discounts.

In 2022, drugmakers raised prices on more than 1,400 drugs according to data published by 46brooklyn, a drug pricing non-profit that is related to 3 Axis. That is the most increases since 2015.

The median drug price increase was 4.9% last year, while the average increase was 6.4%, according to 46brooklyn. Both figures are lower than inflation rates in the United States.

https://www.reuters.com/business/healthcare-pharmaceuticals/drugmakers-raise-prices-least-350-drugs-us-january-2022-12-30/

You would think that elected representatives would care what is happening to their people….but I guess suitcases of cash carried by lobbyists has a a way of blinding the corruptible.

Be prepared for higher outlay for drugs in 2023.

I Read, I Write, You Know

“lego ergo scribo”

The Inflation Reduction Act

Recently the Congress and the White House passed and signed a great bill that is suppose to help struggling Americans keep the prices of drugs down….

The Inflation Reduction Act is set to lower drug prices for millions of people in the U.S. — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many.

The law takes aim at insulin costs, caps out-of-pocket spending for Medicare beneficiaries, and allows the federal government to negotiate prices on the costliest prescription drugs. It also will require drugmakers to pay a rebate to Medicare if they raise prices too sharply.

These provisions won’t be implemented all at once.  Instead, they’ll go into effect gradually over the next several years, beginning with insulin price caps and rebates in 2023, out-of-pocket caps in 2025, and finally drug negotiations in 2026.

Because of the four-year gap before the law is fully implemented, policy and legal experts fear that pharmaceutical companies may have ample time to go on the offense and — if they don’t try to get the law thrown out in court — figure out ways to sidestep provisions that affect their ability to maintain their high profits.

The tactics may ultimately threaten the law’s ability to lower drug costs for consumers. A recent Kaiser Family Foundation survey found about 8 in 10 adults say the cost of prescription drugs is unreasonable.

“Trying to reform the system is like playing three-dimensional chess,” said Robin Feldman, a pharmaceutical and intellectual property law expert at the University of California, Hastings. “Whatever move the government makes, companies will move on three different levels to try to get around it.”

https://www.nbcnews.com/health/health-news/inflation-reduction-act-aims-lower-drug-costs-s-big-pharma-get-rcna48341

This is typical….the Congress installs loopholes that can be exploited by the donors that pay their representatives to make it easier for them exploit the people of this country.

So bend over my fellow Americans and enjoy the ride….you will get use to it (sarcasm)….

I Read, I Write, You Know

“lego ergo scribo”

Pharma Strikes Again

The attempts to try and control the runaway prices for drugs was thwarted by the Senate and Pharma and their suitcases of bribes have struck again.

Senate Republicans knocked a $35 monthly limit on insulin costs for diabetics out of the Democratic economic bill on Sunday. “The reality is the cost of insulin is not just out of control, it is devastating people,” Democratic Sen. Patty Murray said on the floor before the vote, per the Washington Post. Because of a parliamentarian ruling, the measure covering insured patients needed more than the usual simple majority to pass, the Hill reports. The tally was 57-43, with all no votes coming from Republicans. The parliamentarian’s ruling did not affect the similar limit for Medicare patients, which remains in the bill and could have an effect on insulin prices generally.

The House has passed a bill capping the monthly cost of insulin at $35 for insured patients, part of an election-year push by Democrats for price curbs on prescription drugs at a time of rising inflation, per the AP. Experts say the legislation, which passed 232-193 Thursday, would provide significant relief for privately insured patients with skimpier plans and for Medicare enrollees facing rising out-of-pocket costs for their insulin. Some could save hundreds of dollars annually, and all insured patients would get the benefit of predictable monthly costs for insulin. The bill would not help the uninsured. Ten Republicans joined all Democrats in voting for the legislation, notes the New York Times.

The Affordable Insulin Now Act will serve as a political vehicle to rally Democrats and force Republicans who oppose it into uncomfortable votes ahead of the midterms. For the legislation to pass Congress, 10 Republican senators would have to vote in favor to overcome a filibuster. Democrats acknowledge they don’t have an answer for how that’s going to happen, but the political sniping has begun: “If 10 Republicans stand between the American people being able to get access to affordable insulin, that’s a good question for 10 Republicans to answer,” said Rep. Dan Kildee, D-Mich., a cosponsor of the House bill. “Republicans get diabetes, too. Republicans die from diabetes.

Public opinion polls have consistently shown support across party lines for congressional action to limit drug costs. But Rep. Cathy McMorris Rodgers, R-Wash., complained the legislation is only “a small piece of a larger package around government price controls for prescription drugs.” Critics say the bill would raise premiums and fails to target pharmaceutical middlemen seen as contributing to high list prices for insulin. Sen. Chuck Grassley, R-Iowa, said Democrats could have a deal on prescription drugs if they drop their bid to authorize Medicare to negotiate prices. “Do Democrats really want to help seniors, or would they rather have the campaign issue?” Grassley said.

Screwing diabetes sufferers is paramount for the GOP.

Then Pharma goes into full blown fearmongering…..

Groups like this mysterious American Prosperity Alliance (which just launched their website in late June), Pharmaceutical Research and Manufacturers of America (PhRMA) and National Association of Manufacturers have been going all in, dropping millions of dollars on deceptive ads aimed at getting people to oppose drug price negotiation. Meanwhile, Republicans are trying to frame it as “socialist price controls!,” for reasons of “follow the money.”

“I don’t think socializing prices that is putting the government in charge of this is the way to continue the kind of healthy effective pharmaceutical industry that has saved the lives of millions of Americans,” Mitch McConnell said earlier this month.

Although at this point I think that one is probably a hard sell. Polls have shown for years that huge majorities of the country want the government to do far more about the price of pharmaceutical drugs than just letting Medicare negotiate prices.

Too many people have to buy overpriced insulin, Epipens, and too many people remember the time Medicare paid “$172 million between 2006 and 2011, about twice as much as the consumer would have paid at the retail level” for penis pumps for this to be an easy thing to pull off. Many of them have even heard that the government could have saved $3.6 billion by buying Medicare pharmaceuticals from an online pharmacy. Additionally, with inflation being what it is, it’s not gonna be all that easy to get people riled up about “socialist price controls.” When the other option is “getting completely screwed and paying out the nose” for things, “socialist price controls” just don’t sound that menacing.

Of course, allowing Medicare to negotiate prices is not “socialist price controls” anyway, anymore than private insurance companies negotiating prices is “socialist price controls.” In fact, for all intents and purposes, health insurance is a form of collective bargaining. The insurance companies say “We have this many customers, you can sell your drug to our group but only if you charge this much.” That’s why people in countries that have socialized health care pay less for their drugs. Because their whole country is one giant insurance group, which gives them leverage. This is what Medicare should be, but it’s not, because pharmaceutical companies prefer a system where they get to tell the US government how much it is going to pay for drugs and the US government has to pay that amount, regardless of how ridiculous it is.

https://www.wonkette.com/pharma-groups-hope-to-scare-americans-into-letting-them-screw-us-forever

Time for the public to stop bitching and start paying attention…..because eventually your very existence will be at issue.

Turn The Page!

I Read, I Write, You Know

“lego ergo scribo”

One Last ‘Booster’ Thing

I have written several times about the ‘booster’ for Covid….again talk with your medical professional for what is best for you and your family.

When the news first broke about a ‘booster’ my first question was will it be free as well……then I read a story about Pharma and the booster…..

Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus. How much the manufacturers stand to gain depends on how big the rollout proves to be. US health officials late on Thursday endorsed booster shots of the Pfizer vaccine for all Americans 65 and older—along with tens of millions of younger people who are at higher risk from the coronavirus because of health conditions or their jobs, per the AP. Officials described the move as a first step. Boosters will likely be offered even more broadly in the coming weeks or months, including boosters of vaccines made by Moderna and Johnson & Johnson. That, plus continued growth in initial vaccinations, could mean a huge gain in sales and profits for Pfizer and Moderna in particular. “The opportunity quite frankly is reflective of the billions of people around the world who would need a vaccination and a boost,” Jefferies analyst Michael Yee said.

Wall Street is taking notice. The average forecast among analysts for Moderna’s 2022 revenue has jumped 35% since President Joe Biden laid out his booster plan in mid-August. Most of the vaccinations so far in the U.S. have come from Pfizer, which developed its shot with Germany’s BioNTech, and Moderna. They have inoculated about 99 million and 68 million people, respectively. Johnson & Johnson is third with about 14 million people. No one knows yet how many people will get the extra shots. But Morningstar analyst Karen Andersen expects boosters alone to bring in about $26 billion in global sales next year for Pfizer and BioNTech and around $14 billion for Moderna if they are endorsed for nearly all Americans. Those companies also may gain business from people who got other vaccines initially. In Britain, which plans to offer boosters to everyone over 50 and other vulnerable people, an expert panel has recommended that Pfizer’s shot be the primary choice, with Moderna as the alternative.

Andersen expects Moderna, which has no other products on the market, to generate a roughly $13 billion profit next year from all COVID-19 vaccine sales if boosters are broadly authorized. Potential vaccine profits are harder to estimate for Pfizer, but company executives have said they expect their pre-tax adjusted profit margin from the vaccine to be in the “high 20s” as a percentage of revenue. That would translate to a profit of around $7 billion next year just from boosters, based on Andersen’s sales prediction. J&J and Europe’s AstraZeneca have said they don’t intend to profit from their COVID-19 vaccines during the pandemic. For Pfizer and Moderna, the boosters could be more profitable than the original doses because they won’t come with the research and development costs the companies incurred to get the vaccines on the market in the first place.

WBB Securities CEO Steve Brozak said the booster shots will represent “almost pure profit” compared with the initial doses. Drugmakers aren’t the only businesses that could see a windfall from delivering boosters. Drugstore chains CVS Health and Walgreens could bring in more than $800 million each in revenue, according to Jeff Jonas, a portfolio manager with Gabelli Funds. Jonas noted that the drugstores may not face competition from mass vaccination clinics this time around, and the chains are diligent about collecting customer contact information. That makes it easy to invite people back for boosters.

All the news about the boosters leads me to believe that corporate media is hawking this as a necessity….after all profit is more important than health care.

Or is the booster thing being hawked by Biden admin as some sort of payback to Pharma for their giving the ‘jabs’ for free to the population?

Any thoughts?

I Read, I Write, You Know

“lego ergo scribo”

Wasted Along The Way

There has been several reports of the much needed Covid vaccine that has been wasted in one form or another…..and now we know the biggest waste comes from….wait for it……pharma chains…..

Of the 182,874 doses of COVID vaccine wasted in the US as of late March, 128,500 were the responsibility of CVS and Walgreens. A report from Kaiser Health News says almost 50% of the doses reported to the CDC as wasted were supposed to be distributed CVS, and 21% by Walgreens. Those numbers are mostly from the beginning of the vaccination push, per the Guardian. Pfizer and Moderna shots have a very short shelf life once they’re taken out of cold storage: six and five hours, respectively. If a freezer breaks, a syringe malfunctions, or someone doesn’t show up for an appointment, shots may not make it into arms. Indeed, a CVS rep blamed challenges with transportation and “redirecting unused doses,” and said “despite the inherent challenges, our teams were able to limit waste to approximately one dose per onsite vaccination clinic,” Today reports.

The CDC cut the pharmacies some slack. Spokesperson Kate Fowlie said that because they were entrusted with distributing so many shots, “a higher percentage of the overall wastage would not be unexpected, particularly in an early vaccination effort that spanned thousands of locations.” To wit, Walgreens said wasted shots made up less than 0.5% of the more than 8 million doses it successfully distributed through March 29. CVS added that almost all of its unused vaccines were generated early on when it was tasked with vaccinating long-term-care-facility resident and staff. And those late March numbers? They don’t include all the data—the CDC is still gathering information about doses and waste from several states and US territories.

Is this taxpayer cash being wasted?

Not to worry….that is the one thing we do exceptional well….waste money!

Turn The Page!

I Read, I Write, You Know

“lego ergo scribo”

Closing Thought–29Mar21

The pandemic hit and the drug companies went into high gear (with taxpayer money) to find a vaccine to protect the population from this killer…..

Behind the scenes the greed is starting to takeover….

Eager to capitalize on the lasting presence of the coronavirus, executives at Johnson & Johnson, Moderna, and Pfizer—the pharmaceutical corporations that supplied the Covid-19 vaccines approved for use in the U.S.—are quietly planning to hike prices on doses “in the near future,” once they decide the pandemic is over, The Intercept’s Lee Fang reported Thursday.

Although the rapid development of coronavirus vaccines—made possible by large infusions of public resources—has given Big Pharma companies “a boost in goodwill… the public is still sensitive to drug pricing and the reputational risk has, so far, curtailed their ability to reap large financial rewards,” Fang noted. “But that environment, they hope, will change once the pandemic ends: a date that drugmakers themselves reserve the right to declare.”

Many epidemiologists expect the coronavirus to become endemic, “and as Covid-19 mutations continue to spread and booster shots may be required on a regular basis, leaders from the three companies are enthusiastic about cashing in,” wrote Fang.

“As this shifts from pandemic to endemic, we think there’s an opportunity here for us,” Pfizer’s Chief Financial Officer Frank D’Amelio said during a recent healthcare conference sponsored by Barclays Bank. The potential need for booster shots, D’Amelio added, provides “a significant opportunity for our vaccine from a demand perspective, from a pricing perspective, given the clinical profile of our vaccine.”

https://www.commondreams.org/news/2021/03/19/big-pharma-quietly-planning-price-hike-covid-vaccines-near-future-report

This is unacceptable!

If taxpayer money was used to develop the vaccine there should be no profit….or if there is profit then the cash should go where the seed money originated…..the US treasury.

Time for the American people to see the fruits of their taxes.

I Read, I Write, You Know

“lego ergo scribo”

Now More Bad News

Bad news for those that depend on drugs to keep them healthy and well…..like insulin, et al……

The bad news is Big Pharma has stated that there will be major drug increases at the beginning of the New Year…..like they need the increased cash.

As a result of the coronavirus pandemic, hospitalizations skyrocketed in 2020, but routine visits to the doctor’s office and demand for new prescription medications fell sharply during the worldwide lockdown.

To make up for lost revenue, the pharmaceutical industry plans to ring in the New Year by raising prices on more than 300 drugs in the United States on January 1, according to an analysis by healthcare consulting firm 3 Axis Advisors, whose findings were summarized in an exclusive report published Thursday in Reuters.

As Reuters pointed out, “The increases come as pharmaceutical companies like Pfizer are playing hero by developing vaccines for Covid-19 in record time.”

While scientific advances made by pharmaceutical companies have contributed to defeating the pandemic, critics argue that it would be naive to assume the industry is simply motivated to improve people’s well-being.

“Big Pharma’s greed is a danger to public health,” Reps. Pramila Jayapal (D-Wash.) and Mark Pocan (D-Wis.) said earlier this year, when Gilead announced that it would charge U.S. hospitals $3,120 per privately insured patient for a treatment course of remdesivir, a Covid-19 drug whose development was financed in large part by taxpayers.

Pfizer spokesperson Amy Rose pointed to the coronavirus vaccine the company developed with Germany’s BioNTech in an attempt to justify next year’s drug price hikes. “This modest increase,” Rose said in a statement, “is necessary to support investments that allow us to continue to discover new medicines and deliver those breakthroughs to the patients who need them.”

Nevertheless, as David Mitchell, a cancer patient and founder of Patients for Affordable Drugs Now, said last month, “Drugs don’t work if people can’t afford them.”

https://www.commondreams.org/news/2020/12/31/drugs-dont-work-if-people-cant-afford-them-big-pharma-raise-prices-300-medications

What about all those vaccines to fight the Covid-19?

The Pfizer vaccine, also given in two doses, is expected to cost $19.50 a dose. Each dose for Johnson & Johnson’s two-dose vaccine will cost an estimated $10, and AstraZeneca’s two-dose vaccine could be the cheapest at just $3 to $4 a dose.

Am I wrong or did these companies get taxpayer money to expedite a vaccine?  If so  why should they make any money off the vaccines?

Do they think that because they are taunted as “heroes” because the pandemic will change the fact that they are raping the American people?

Time for these parasites to be put in their place as servants of mankind not the ruler.

I Read, I Write, You Know

“lego ergo scribo”

Atta Boys!

This post is for those people that show up only occasionally when I write something derogatory about Herr Trump…..actually I have written several times about some of the policies that Trump is embracing that I would approve of….but that does not get the slower out there to show up.

I have agreed with Trump on some of his foreign policy issues….like bringing our troops home….and just the other day I saw another issue that I would give him an “atta boy”…..drug prices.

President Trump is reportedly set to sign an executive order Friday to reduce prescription-drug costs.

The president’s election-year effort was first reported by The Hill newspaper, which obtained an invitation sent to some GOP lawmakers for a 3 p.m. White House event on drug pricing. 

The exact details of the executive order remain unclear. But sources told the newspaper that it could include a version of an existing proposal to lower the price of some U.S. drugs by connecting them to lower prices paid in other countries.

https://justthenews.com/government/white-house/trump-likely-sign-executive-order-lower-prescription-drug-costs-us

Please I have NO illusion that this is just a way to gain a little support when poll numbers ware waning……but if it saves me money on my drugs then he has my thanks.

And yet another “atta boy” for Trump……

We all know that Trump is a voracious Twitter user, right?

And I have often asked myself he actually knows what he is Tweeting…..well I have an answer to my rhetorical question.

President Trump acknowledged in an interview released Friday that he “often” regrets his tweets and retweets.

“It used to be in the old days before this, you’d write a letter and you’d say, ‘this letter is really bad,’ you put it on your desk and you go back tomorrow and you say, ‘oh, I’m glad I didn’t send it,’” Trump told Barstool Sports’ founder Dave Portnoy.

“But we don’t do that with Twitter. We put it out instantaneously, we feel great, and then you start getting phone calls, ‘Did you really say this?’ I say, ‘What’s wrong with that?’ And you find a lot of things,” continued the president, who is often the subject of criticism over his use of his Twitter account. “You know what I find? It’s not the tweets, it’s the retweets that get you in trouble.”

Trump went on to say he doesn’t always look closely at the tweets that he shares from his Twitter account, which has 84 million followers.

He had similarly said that some of his tweets create problems for the White House in an interview last year.

https://thehill.com/homenews/administration/508947-trump-says-he-often-regrets-his-tweets-and-retweets

My question is if you realize that some of your Tweets are not good at all….why continue to do it?

Is it an addiction that he cannot break?

Just Wondering!

I Read, I Write, You Know

“lego ergo scribo”